These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy. Gongvatana A; Harezlak J; Buchthal S; Daar E; Schifitto G; Campbell T; Taylor M; Singer E; Algers J; Zhong J; Brown M; McMahon D; So YT; Mi D; Heaton R; Robertson K; Yiannoutsos C; Cohen RA; Navia B; J Neurovirol; 2013 Jun; 19(3):209-18. PubMed ID: 23613008 [TBL] [Abstract][Full Text] [Related]
43. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. Heaton RK; Franklin DR; Ellis RJ; McCutchan JA; Letendre SL; Leblanc S; Corkran SH; Duarte NA; Clifford DB; Woods SP; Collier AC; Marra CM; Morgello S; Mindt MR; Taylor MJ; Marcotte TD; Atkinson JH; Wolfson T; Gelman BB; McArthur JC; Simpson DM; Abramson I; Gamst A; Fennema-Notestine C; Jernigan TL; Wong J; Grant I; ; J Neurovirol; 2011 Feb; 17(1):3-16. PubMed ID: 21174240 [TBL] [Abstract][Full Text] [Related]
44. Impact of aging on neurocognitive performance in previously antiretroviral-naive HIV-infected individuals on their first suppressive regimen. Coban H; Robertson K; Smurzynski M; Krishnan S; Wu K; Bosch RJ; Collier AC; Ellis RJ AIDS; 2017 Jul; 31(11):1565-1571. PubMed ID: 28471765 [TBL] [Abstract][Full Text] [Related]
45. HIV-associated dementia in the era of highly active antiretroviral therapy (HAART). Xia C; Luo D; Yu X; Jiang S; Liu S Microbes Infect; 2011 May; 13(5):419-25. PubMed ID: 21262373 [TBL] [Abstract][Full Text] [Related]
46. Impact of current antiretroviral therapies on neuroAIDS. Vivithanaporn P; Gill MJ; Power C Expert Rev Anti Infect Ther; 2011 Apr; 9(4):371-4. PubMed ID: 21504390 [No Abstract] [Full Text] [Related]
47. Antiretroviral therapy and central nervous system HIV type 1 infection. Price RW; Spudich S J Infect Dis; 2008 May; 197 Suppl 3(Suppl 3):S294-306. PubMed ID: 18447615 [TBL] [Abstract][Full Text] [Related]
48. Neurocognitive dysfunction in the highly active antiretroviral therapy era. Mothobi NZ; Brew BJ Curr Opin Infect Dis; 2012 Feb; 25(1):4-9. PubMed ID: 22156897 [TBL] [Abstract][Full Text] [Related]
49. HIV-associated neurocognitive disorders and the impact of combination antiretroviral therapies. Ances BM; Clifford DB Curr Neurol Neurosci Rep; 2008 Nov; 8(6):455-61. PubMed ID: 18957181 [TBL] [Abstract][Full Text] [Related]
50. Effects of antiretroviral therapy on cognitive impairment. Liner KJ; Hall CD; Robertson KR Curr HIV/AIDS Rep; 2008 May; 5(2):64-71. PubMed ID: 18510891 [TBL] [Abstract][Full Text] [Related]
51. Association of age and time of disease with HIV-associated neurocognitive disorders: a Japanese nationwide multicenter study. Kinai E; Komatsu K; Sakamoto M; Taniguchi T; Nakao A; Igari H; Takada K; Watanabe A; Takahashi-Nakazato A; Takano M; Kikuchi Y; Oka S; J Neurovirol; 2017 Dec; 23(6):864-874. PubMed ID: 28971376 [TBL] [Abstract][Full Text] [Related]
52. Progress in clinical neurosciences: The neuropathogenesis of HIV infection: host-virus interaction and the impact of therapy. Power C; Gill MJ; Johnson RT Can J Neurol Sci; 2002 Feb; 29(1):19-32. PubMed ID: 11858531 [TBL] [Abstract][Full Text] [Related]
54. Macrophages but not Astrocytes Harbor HIV DNA in the Brains of HIV-1-Infected Aviremic Individuals on Suppressive Antiretroviral Therapy. Ko A; Kang G; Hattler JB; Galadima HI; Zhang J; Li Q; Kim WK J Neuroimmune Pharmacol; 2019 Mar; 14(1):110-119. PubMed ID: 30194646 [TBL] [Abstract][Full Text] [Related]
56. HIV Neuropathogenesis in the Presence of a Disrupted Dopamine System. Nickoloff-Bybel EA; Calderon TM; Gaskill PJ; Berman JW J Neuroimmune Pharmacol; 2020 Dec; 15(4):729-742. PubMed ID: 32506353 [TBL] [Abstract][Full Text] [Related]
57. Empiric neurocognitive performance profile discovery and interpretation in HIV infection. Gomez D; Power C; Gill MJ; Koenig N; Vega R; Fujiwara E J Neurovirol; 2019 Feb; 25(1):72-84. PubMed ID: 30519968 [TBL] [Abstract][Full Text] [Related]
58. Neurocognitive impairment in HIV-infected naïve patients with advanced disease: the role of virus and intrathecal immune activation. Airoldi M; Bandera A; Trabattoni D; Tagliabue B; Arosio B; Soria A; Rainone V; Lapadula G; Annoni G; Clerici M; Gori A Clin Dev Immunol; 2012; 2012():467154. PubMed ID: 22489249 [TBL] [Abstract][Full Text] [Related]
59. Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications. Hong S; Banks WA Brain Behav Immun; 2015 Mar; 45():1-12. PubMed ID: 25449672 [TBL] [Abstract][Full Text] [Related]
60. HIV-Associated Neurocognitive Disorders--An issue of Growing Importance. Chan LG; Wong CS Ann Acad Med Singap; 2013 Oct; 42(10):527-34. PubMed ID: 24254240 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]